牛FFAR2/GPR43的内源配体具有独特的药理性质
Tainara Cristina Michelotti1, Valérie Lamothe2, Frédéric Jean-Alphonse3,4
1INRAE, Université Clermont Auvergne, VetAgro Sup, UMR Herbivores, Saint-Genès-Champanelle, France.
Frontiers in cell and developmental biology
|September 5, 2025
概括
牛自由脂肪酸受体2 (bFFAR2) 信号由短链和中链脂肪酸激活. 脂肪酸结构,特别是碳的长度和分支,影响了bFFAR2的功效和下游效应.
科学领域:
- 药理学和分子生物学
- G蛋白结合受体 (GPCR) 信号传递
- 脂质代谢和信号传递
背景情况:
- 自由脂肪酸 (FFAs) 是自由脂肪酸受体 (FFARs) 的内源性配体,GPCRs的一个子家族.
- FFAR2在各种生理过程中发挥作用,使其成为潜在的治疗点.
- 牛FFAR2 (bFFAR2) 的药理表征仍然不完整.
研究的目的:
- 通过一系列FFA来研究bFFAR2信号的激活和调节.
- 阐明短链和中链FFA在bFFAR2上的结构-活性关系.
主要方法:
- 使用HEK293A细胞来评估bFFAR2的活性.
- 生物发光共振能量转移 (BRET) 试验用于测量G蛋白合 (Gαi/Gαq) 和β-arrestin 2的招募.
- 用于评估转录激活 (SRE和NFAT-RE) 的是露西法酶记者测定.
主要成果:
- bFFAR2表现出对Gαi和Gαq的双重合,并在FFAs刺激后使用β-arrestin2达到C8: 0.
- 具有4-7碳和3-甲基butan酸的FFAs在激活bFFAR2方面表现最强.
- 甲基酸 (2MP) 显示了最小的β-arrestin2活性和有限的受体内化,没有早期的内体贩运.
结论:
- bFFAR2的激活和信号由直链FFA的碳链长度和分支FFA的甲基位置不同调节.
- 了解这些结构-活性关系对于开发调节bFFAR2的向疗法至关重要.
- 需要进行进一步的研究,以完全描述各种FFA对bFFAR2激活的下游后果.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
G Protein-coupled Receptors
13.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.2K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Drug-Receptor Interactions
5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K


